Q2 GAAP revenue of $209.3 million increased 335% year-over-year, driven by recently closed M&A transactions. Q2 proforma revenue of $254.9 million, gives effect to the acquisitions of Hawthorne, Bridgewell, and PharmaCann as if they were completed on April 1,…

Additional Information
Additional information relating to the Companys second quarter 2026 results will be available on EDGAR and SEDAR+ later today. Vireo refers to certain non-GAAP financial measu…